Amesite Inc. (AMST)
NASDAQ: AMST · Real-Time Price · USD
5.11
+0.93 (22.25%)
At close: Dec 20, 2024, 4:00 PM
4.860
-0.250 (-4.89%)
After-hours: Dec 20, 2024, 6:04 PM EST
Company Description
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States.
Its products include Amesite Engage that enables colleges and universities to offer courses and programs that build professional skills; and NurseMagic, a healthcare app that specifically targets the segments in healthcare, including nurses and caregivers offering support to do jobs, manage stress, complete documentation, and perform other tasks.
It serves enterprises, universities, and K-12 schools. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
Amesite Inc.
Country | United States |
Founded | 2017 |
IPO Date | Sep 25, 2020 |
Industry | Software - Application |
Sector | Technology |
Employees | 9 |
CEO | Ann Sastry |
Contact Details
Address: 607 Shelby Street, Suite 700 Detroit, Michigan 48226 United States | |
Phone | (734) 876-8130 |
Website | amesite.com |
Stock Details
Ticker Symbol | AMST |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | USD |
IPO Price | $5.00 |
CIK Code | 0001807166 |
CUSIP Number | 031094105 |
ISIN Number | US0310942042 |
Employer ID | 82-3431717 |
SIC Code | 7372 |
Key Executives
Name | Position |
---|---|
Dr. Ann Marie Sastry Ph.D. | Chairperson, President and Chief Executive Officer |
Sherlyn W. Farrell | Chief Financial Officer |
Brandon Owens | Vice President of Sales |
Kalie Wortinger | Senior Manager of Engineering |
Jay Majumdar | Vice President of Partnerships |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 18, 2024 | EFFECT | Notice of Effectiveness |
Dec 13, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
Dec 3, 2024 | 8-K | Current Report |
Nov 27, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Nov 27, 2024 | ARS | Filing |
Nov 27, 2024 | DEF 14A | Other definitive proxy statements |
Nov 26, 2024 | 8-K | Current Report |
Nov 14, 2024 | 10-Q | Quarterly Report |
Nov 5, 2024 | S-3 | Registration statement under Securities Act of 1933 |
Sep 30, 2024 | 10-K | Annual Report |